Skip to main content


The FTC is currently reviewing claims and will post updates here when we have more information.

In 2019 and 2020, the Federal Trade Commission (FTC) reached settlements with the companies responsible for Suboxone®, a prescription drug used to treat opioid addiction. The FTC says that these companies violated antitrust laws by preventing patients from choosing lower-priced generic versions of the drug.

In May 2021, the FTC sent payments totaling more than $59 million to people who filed a valid claim.

The FTC is now reviewing claims from people who contacted the claims administrator after the original deadline and asked to be added to the waitlist. There is approximately $500,000 left in the settlement fund.

If you have questions, please call the refund administrator at 1-877-545-0238.